相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Three-Year Outcomes With the Absorb Bioresorbable Scaffold: Individual-Patient-Data Meta-Analysis From the ABSORB Randomized Trials
Ziad A. Ali et al.
CIRCULATION (2018)
Bioresorbable stents: Current and upcoming bioresorbable technologies
Hui Ying Ang et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
6-Month Clinical and Angiographic Outcomes of a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold The FANTOM II Study
Alexandre Abizaid et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2017)
Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions
Alexandre Abizaid et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2016)
Vasomotor Function Comparative Assessment at 1 and 2 Years Following Implantation of the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold and the Xience V Everolimus-Eluting Metallic Stent in Porcine Coronary Arteries Insights From In Vivo Angiography, Ex Vivo Assessment, and Gene Analysis at the Stented/Scaffolded Segments and the Proximal and Distal Edges
Bill D. Gogas et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2016)
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial
Patrick W. Serruys et al.
LANCET (2016)
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial
Michael Haude et al.
LANCET (2016)
1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis
Gregg W. Stone et al.
LANCET (2016)
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease
Stephen G. Ellis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Current Status of Bioresorbable Scaffolds in the Treatment of Coronary Artery Disease
Jens Wiebe et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Comparison of In Vivo Acute Stent Recoil Between the Bioresorbable Everolimus-Eluting Coronary Scaffolds (Revision 1.0 and 1.1) and the Metallic Everolimus-Eluting Stent
Yoshinobu Onuma et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2011)
Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings
Kumaran Kolandaivelu et al.
CIRCULATION (2011)
Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis Six-Month Clinical and Imaging Outcomes
Patrick W. Serruys et al.
CIRCULATION (2010)
A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial
John A. Ormiston et al.
LANCET (2008)
Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer
E Grube et al.
CIRCULATION (2004)
Intracoronary stenting and angiographic results:: Strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial
J Pache et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions
E Grube et al.
CIRCULATION (2003)
Hydrolytic degradation of tyrosine-derived polycarbonates, a class of new biomaterials. Part I: Study of model compounds
V Tangpasuthadol et al.
BIOMATERIALS (2000)
分享论文
